Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

88.600
-3.050-3.33%
Volume:6.34M
Turnover:580.95M
Market Cap:49.94B
PE:60.73
High:96.650
Open:92.950
Low:86.800
Close:91.650
52wk High:126.600
52wk Low:19.400
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:1.55
T/O Rate:3.04%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.459
ROE:32.91%
ROA:-9.72%
PB:19.03
PE(LYR):60.73
PS:13.58

Loading ...

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31, 2025

RemeGen Co., Ltd.* (9995) Announces 2025 Third Quarter Results

Bulletin Express
·
Oct 30, 2025

RemeGen (9995) Announces Renewals of Continuing and One-off Connected Transactions

Bulletin Express
·
Oct 30, 2025

Visual Guide to REMEGEN's Q3 2025 Earnings Report

Deep News
·
Oct 30, 2025

REMEGEN (09995) Reports Q3 Results: Net Loss Narrows 48.6% YoY to RMB 551 Million

Stock News
·
Oct 30, 2025

HK Stock Connect Shareholding Changes as of October 30

Stock News
·
Oct 30, 2025

Caitong Securities: Phosphoramidite Monomer Demand to Boom, Companies in MNC Pharma Supply Chains Set to Benefit

Stock News
·
Oct 29, 2025

HK Stock Connect Shareholding Changes | Oct 28

Stock News
·
Oct 28, 2025

RemeGen (SEHK:9995) Is Down 8.4% After Breakthrough Phase III Results Gain Global Recognition – Has the Bull Case Changed?

Simply Wall St.
·
Oct 26, 2025

Asian Growth Companies With High Insider Ownership In October 2025

Simply Wall St.
·
Oct 22, 2025

RemeGen (9995) Schedules Board Meeting on October 30, 2025 to Review Unaudited Third Quarterly Results

Bulletin Express
·
Oct 17, 2025

Hong Kong Stock Market Analysis | Various Manipulations Behind Many Strategies and Severe Volume Reduction Favours Consumer Giants

Stock News
·
Oct 16, 2025

Stock Track | REMEGEN Soars 6.36% as Lupus Treatment Study Published in Prestigious Medical Journal

Stock Track
·
Oct 16, 2025

Hong Kong Stocks Update: REMEGEN (09995) Rises Over 5% After NEJM Publication of Lupus Treatment Study

Stock News
·
Oct 16, 2025

RemeGen (SEHK:9995): Assessing Valuation After 25% Revenue Growth and a 2% Share Price Gain

Simply Wall St.
·
Oct 16, 2025

REMEGEN (09995) Purchases 500 Million Yuan Financial Products

Stock News
·
Oct 15, 2025

Stock Track | REMEGEN Soars 5.31% as Telitacicept Gains Regulatory Traction and New Leadership Appointment

Stock Track
·
Oct 15, 2025

Hong Kong Stock Movement | REMEGEN (09995) Surges Nearly 5% in Early Trading as Telitacicept's IgA Nephropathy Treatment Application Receives Acceptance and Priority Review

Stock News
·
Oct 15, 2025

Biotech Stocks Jump. Immunotech up 17%; Carsgen up 14%; BRII up 6%; JW Therap up 4%; Sirnaomics up 3%

Tiger Newspress
·
Oct 06, 2025

Selling CN¥67m Of RemeGen Stock Rewarded Insiders

Simply Wall St.
·
Oct 06, 2025